Catalog |
name |
Description |
price |
R-M1-cs8806 |
RVG29 modified liposomes loaded with paclitaxel |
The RVG29 modification on the liposomes provides a targeted approach to deliver paclitaxel specifically to neuronal cells, potentially for the treatment of neurological disorders or brain tumors. The RVG29 peptide interacts with nAChR on neuronal cells, promoting the endocytosis of the liposomes and subsequent release of the paclitaxel within the targeted cells.RVG29 modified liposomes loaded with paclitaxel offer the benefit of targeted drug delivery to neuronal cells, improving the efficacy and selectivity of paclitaxel treatment.RVG29 is a peptide derived from the rabies virus glycoprotein, which has a high affinity for the neuronal acetylcholine receptor (nAChR), specifically present on neuronal cells. By modifying liposomes with RVG29, they can be targeted specifically to neuronal cells, allowing for enhanced drug delivery to these cells. |
price> |
R-M1-cs8807 |
Liposome loaded tectorigenin,surface modified peptide APWHLSSQYSRT |
The combination of liposome loaded tectorigenin and surface-modified peptide APWHLSSQYSRT refers to the preparation of liposomes that encapsulate tectorigenin, a natural compound, while the surface of the liposomes is modified with the peptide sequence APWHLSSQYSRT.
Surface modification of liposomes with peptides, such as APWHLSSQYSRT, offers a way to enhance drug delivery and target specific cells or tissues. The sequence of the peptide may have been specifically designed to interact with a receptor or biomarker present on the surface of target cells. |
price> |
R-M1-cs8810 |
SS31 peptide/simvastatin @ ROS responsive liposome |
By encapsulating SS31 peptide and simvastatin within ROS-responsive liposomes, it may be possible to achieve targeted delivery of both compounds to areas of high ROS levels, such as in certain disease states. The ROS-responsive liposomes are designed to release the encapsulated SS31 peptide and simvastatin in response to the presence of ROS, allowing for localized therapeutic effects and potentially enhanced efficacy.
This combination could be explored in various biomedical applications, including the treatment of oxidative stress-related disorders or conditions where ROS plays a significant role, such as cardiovascular diseases, neurodegenerative disorders, or inflammation-associated conditions. |
price> |
R-M1-8887 |
Fluvoxamine@LNP-TFR (sequence:THRPPMWSPVWP) 100nm |
The Fluvoxamine@Liposome nanoparticles-TFR (sequence: THRPPMWSPVWP) involves the targeted delivery of the therapeutic drug fluvoxamine using liposome nanoparticles functionalized with a peptide sequence that targets transferrin receptors. This type of drug delivery system has the potential to enhance the specificity and efficiency of drug delivery to particular cells or tissues in the body. |
price> |
R-M1-8303 |
cRGD-liposomes @temozolomide and erastin |
cRGD-liposomes @temozolomide and erastin,Polypeptide cRGD modified liposomes coated with Temozolomide and erastin from kamulin. |
price> |
R-M1-8386 |
Gold nanoparticles (15nm)-GSH |
Glutathione (GSH) is a water-soluble tripeptide that is contained in biological fluids (blood, cell fluid) and plays an important role in the redox process of human and animal organisms. Gold nanoparticles modified graphite electrodes have electrocatalytic activity for the oxidation of glutathione in alkaline media. |
price> |
R-M1-8387 |
Gold nanoparticles (15nm)-Cys |
Gold nanoparticles (15nm)-Cys,Gold nanoparticles (AuNPs)-cysteine (C)
It can be used for research in fields such as targeted delivery and biological imaging. It can be customized into Gold nanoparticles (AuNPs) wrapped in different sizes of cysteine (C).
Gold nanoparticles (AuNPs) have their high stability, biocompatibility and
functionality. |
price> |
R-M1-8395 |
Peptide-DID liposomes@doxorubicin |
Peptide-DID liposomes@doxorubicin,Peptide modified fluorescent DID liposomes loaded with doxorubicin from ruixibio.DiD(1,1-Dioctadecyl-3,3,3,3-tetramethylindodicarbocyanine)is a lipophilic fluorescent dye, which can be used to dye cell membrane and other liposoluble biological structures. The fluorescence intensity of these environmentally sensitive fluorescent dyes is very weak before they enter the cell membrane, and increases greatly when they combine with the cell membrane. It has the characteristics of high extinction coefficient, dependence and short lifetime of excited state. |
price> |
R-M1-8427 |
(CRGD+TAT)-liposomes @ polydopamine loaded RNA |
CRGD+TAT co-modified liposomes encapsulating polydopamine-loaded RNA represent a targeted delivery system that combines the properties of liposomes, polydopamine, and targeting peptides to improve the stability, targeting, and cellular uptake of RNA molecules for various applications, including gene therapy or RNA-based therapeutics. |
price> |
R-M1-8641 |
Sodium thiohydride/CY5 @SiO2@Lipid nanoparticles-targeted peptide/Dil |
Sodium thiohydride/CY5 @ mesoporous silicon @ Lipid nanoparticles-targeted peptide/Dil suggests a potential system for targeted drug delivery using microparticles or nanoparticles. This system could potentially allow for the release of hydrogen sulfide, the visualization of the particles using CY5 fluorescence, and the targeted delivery of nucleic acids or drugs to specific cells or tissues using the LNP-targeting peptide Dil. The specific application and functionality of this compound would depend on the intended purpose and experimental requirements. |
price> |